Literature DB >> 12803919

The fate and function of glycosphingolipid glucosylceramide.

Gerrit van Meer1, Jasja Wolthoorn, Sophie Degroote.   

Abstract

In higher eukaryotes, glucosylceramide is the simplest member and precursor of a fascinating class of membrane lipids, the glycosphingolipids. These lipids display an astounding variation in their carbohydrate head groups, suggesting that glycosphingolipids serve specialized functions in recognition processes. It is now realized that they are organized in signalling domains on the cell surface. They are of vital importance as, in their absence, embryonal development is inhibited at an early stage. Remarkably, individual cells can live without glycolipids, perhaps because their survival does not depend on glycosphingolipid-mediated signalling mechanisms. Still, these cells suffer from defects in intracellular membrane transport. Various membrane proteins do not reach their intracellular destination, and, indeed, some intracellular organelles do not properly differentiate to their mature stage. The fact that glycosphingolipids are required for cellular differentiation suggests that there are human diseases resulting from defects in glycosphingolipid synthesis. In addition, the same cellular differentiation processes may be affected by defects in the degradation of glycosphingolipids. At the cellular level, the pathology of glycosphingolipid storage diseases is not completely understood. Cell biological studies on the intracellular fate and function of glycosphingolipids may open new ways to understand and defeat not only lipid storage diseases, but perhaps other diseases that have not been connected to glycosphingolipids so far.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803919      PMCID: PMC1693184          DOI: 10.1098/rstb.2003.1266

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  33 in total

Review 1.  The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis.

Authors:  Graça Raposo; Michael S Marks
Journal:  Traffic       Date:  2002-04       Impact factor: 6.215

2.  Cell biology. The different hues of lipid rafts.

Authors:  Gerrit van Meer
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

3.  Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles.

Authors:  P Kantheti; X Qiao; M E Diaz; A A Peden; G E Meyer; S L Carskadon; D Kapfhamer; D Sufalko; M S Robinson; J L Noebels; M Burmeister
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

4.  A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3.

Authors:  S Höning; I V Sandoval; K von Figura
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

5.  Lipid rafts reconstituted in model membranes.

Authors:  C Dietrich; L A Bagatolli; Z N Volovyk; N L Thompson; M Levi; K Jacobson; E Gratton
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

6.  Cloning and expression of glycolipid transfer protein from bovine and porcine brain.

Authors:  X Lin; P Mattjus; H M Pike; A J Windebank; R E Brown
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

Review 7.  Mammalian ABC transporters in health and disease.

Authors:  P Borst; R Oude Elferink
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

8.  Assay for the transbilayer distribution of glycolipids. Selective oxidation of glucosylceramide to glucuronylceramide by TEMPO nitroxyl radicals.

Authors:  D J Sillence; R J Raggers; D C Neville; D J Harvey; G van Meer
Journal:  J Lipid Res       Date:  2000-08       Impact factor: 5.922

Review 9.  Biosynthesis and degradation of mammalian glycosphingolipids.

Authors:  Konrad Sandhoff; Thomas Kolter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

10.  The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane.

Authors:  R J Raggers; A van Helvoort; R Evers; G van Meer
Journal:  J Cell Sci       Date:  1999-02       Impact factor: 5.285

View more
  21 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Glucosylceramide synthesis inhibition affects cell cycle progression, membrane trafficking, and stage differentiation in Giardia lamblia.

Authors:  Sasa Stefanić; Cornelia Spycher; Laura Morf; Gemma Fabriàs; Josefina Casas; Elisabeth Schraner; Peter Wild; Adrian B Hehl; Sabrina Sonda
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.

Authors:  Christina M Ridley; Karen E Thur; Jessica Shanahan; Nagendra Babu Thillaiappan; Ann Shen; Karly Uhl; Charlotte M Walden; Ahad A Rahim; Simon N Waddington; Frances M Platt; Aarnoud C van der Spoel
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

5.  Glucosylceramide transfer from lysosomes--the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data.

Authors:  M Elleder
Journal:  J Inherit Metab Dis       Date:  2006-11-02       Impact factor: 4.982

6.  Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction.

Authors:  Teruo Hayashi; Michiko Fujimoto
Journal:  Mol Pharmacol       Date:  2010-01-06       Impact factor: 4.436

Review 7.  Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.

Authors:  Aarnoud C van der Spoel; Richard Mott; Frances M Platt
Journal:  Pharmacogenomics       Date:  2008-06       Impact factor: 2.533

8.  Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).

Authors:  Akhtar Siddiqui; Vineet Gupta; Yong-Yu Liu; Sami Nazzal
Journal:  Int J Pharm       Date:  2012-04-25       Impact factor: 5.875

Review 9.  Future perspectives for glycolipid research in medicine.

Authors:  Timothy M Cox
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

10.  A historical perspective of the glycosphingolipids and sphingolipidoses.

Authors:  Richard W E Watts
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.